As a result of the entry into force of Regulation (EU) 2023/741 of 5 April 2023 concerning the non-renewal of oxamyl approval, 3 authorisations for plant […]
Work aimed at anticipating the withdrawal of the highest concern active substances and reinforcing the mobilisation of the stakeholders concerned to broaden the range of solutions […]